Clinical Decision and Support System Market is Expected To Witness a CAGR of 11.69 % By 2026 | Explore By Top Players IBM Watson Health, GE Healthcare, Siemens Healthineers, Philips Healthcare, Allscripts Healthcare Solutions, Inc.

Clinical decision support system is IT-based tool that assists doctors and nurses by providing actionable inputs about patient for enhancement of health outcome of patient. This system provides customized, patient specific clinical information, which improves quality of care. Various tools in the clinical decision support system include computerized alerts and reminders to care providers and patients, clinical guidelines and protocols, condition-specific order sets, focused patient data reports and summaries, smart documentation templates, diagnostic support, multipatient monitors and dashboards, contextually relevant reference information, and predictive and retrospective analytics. Clinical decision support system provide different benefits such as reduction in clinical error and adverse events, improved quality of healthcare service, increased efficiency and reduction in overall healthcare cost. Clinical decision support system is one of emerging healthcare technology designed to improve clinical decision making, this system could address the problem of clinical information burden faced by healthcare providers in routine decision making. Clinical decision support system provides a platform for integrating evidence-based knowledge into care delivery that improves clinical outcome.

The global clinical decision support system market size was valued at US$ 767.4 million in 2017, and is expected to witness a CAGR of 11.69 % over the forecast period (2018 – 2026).

Get FREE In-Depth Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/2054

Market Dynamics:

Major driver for growth of the clinical decision support system market is various benefits offered by the CDSS in both inpatient settings, ambulatory settings, and clinics. Medical error is one of the significant contributor to cause of death worldwide. According to data published by Centre for Disease Control and Prevention (CDC), 2013, more than 150,000 deaths are reported annually in the U.S. due to medical error (ADR, wrong diagnosis, prescription error)

According to World Health Organization (WHO) report, in 2017, medication error costs US$ 42 billion annually worldwide. An estimated 43 million patient safety incidence occur annually and around 1 in 10 patient get harmed due to medication error while receiving healthcare. These incidence of medication error could be addressed with use of CDSS. Increasing prevalence of chronic disease is another driver for wide adoption of CDSS. According to WHO Factsheet, around 73% of global deaths are expected to be from chronic disease by 2020.

Increasing chronic disease prevalence worldwide to propel growth of the clinical decision support system market

Increasing prevalence of the chronic disease such as cancer, diabetes, and cardiovascular disease worldwide is propelling demand for its accurate diagnosis, treatment plan, and continuous care. According to the data published by American Heart Association, in 2016, annual cost of cardiovascular disease and stroke in 2011 – 2012 was US$ 193.1 billion in medical care and about US$ 123 billion in lost productivity from premature death. This cost can be reduced by adopting clinical decision support system, which could prevent and control major risk factors for CVD such as hypertension, hypercholesterolemia, and diabetes.

However, CDSS system has few limitation in its operation, which may hinder growth of the clinical decision support system market.

1. CDSS must integrate with a healthcare provider’s clinical workflow, which is often complex task. Incorporating large amounts of data into existing systems places significant strain on application and infrastructure maintenance
2. Few clinical decision support systems ,which are stand-alone lack facility for integration with EHR system, which may lead to repetition of task
3. Updating development in clinical data on regular basis from ongoing clinical research and medical trials is challenging, as vast number of research and medical trials are being published every day.

Competitive Analysis:

Key players operating in the clinical decision support system market include

1. Cerner Corporation
2. Allscripts Healthcare Solutions, Inc.
3. IBM Watson Health
4. GE Healthcare
5. Change Healthcare
6. Zynx Health
7. Carestream Health Inc.
8. First Databank, Inc.
9. NextGen Healthcare Information Systems
10. Agfa Healthcare
11. Medical Information Technology Inc.
12. Athena Health
13. Wolters Kluwer NU
14. Siemens Healthineers
15. Philips Healthcare

Detailed Segmentation:

By Product: Stand Alone CDSS, Integrated CDSS
By Component: Hardware, Software, Services
By Delivery Mode: On Premise CDSS, Web/Cloud based CDSS
By Applications: Diagnosis Support, Prescription support, Clinical Reminders and Guidelines, Others
By End User: Hospitals, Clinics, Ambulatory Care centers, Others
By Geography: North America, Europe, Asia Pacific, Latin America, Middle East, Africa

Else place an Inquire before Purchase “Global Clinical Decision and Support System Market Size, Status and Forecast 2026": https://www.coherentmarketinsights.com/insight/talk-to-analyst/2054

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.